08/11/2024  17:35:15 Var. +2.15 Volume Denaro17:35:15 Lettera17:35:15 Capitalizzazione di mercato Dividend Y. Rapporto P/E
363.80GBX +0.59% 2.82 mill.
Fatturato(GBP): 10.23 mill.
-Quantità in denaro: - -Quantità in lettera: - 33.75 bill.GBP - -

Descrizione business

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. It provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Brian McNamara
Consiglio di amministrazione
Tobias Hestler, Keith Choy, Filippo Lanzi, Mairéad Nayager, Lisa Paley, Franck Riot, Tamara Rogers, Bjarne Philip Tellmann, Ed Petter, Björn Timelin, Namrata Patel
Consiglio di sorveglianza
Sir Dave Lewis , Brian McNamara , Tobias Hestler, Mavinder Singh (Vindi) Banga , Marie-Anne Aymerich , Tracy Clarke, Dame Vivienne Cox, Asmita Dubey, Deirdre Mahlan, Bryan Supran, David (Dave) Denton
 

Dati aziendali

Name: Haleon PLC
Indirizzo: The Heights Building 5, First Floor The Heights,Surrey KT13 0NY
Telefono: -
Fax: -
E-mail: -
Internet: https://www.haleon.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: -
IR telefono: -
IR Fax: -
IR e-mail: investor-relations@haleon.com

Company calendar

CW 10 | 05/03/2025 4th Quarter/Annual Report
 

Principali azionisti

Altri
 
55.00%
Pfizer
 
32.00%
GSK
 
13.00%